Is PDLI A Good Stock To Buy Now?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed...
Posts Tagged ‘NASDAQ:PDLI’
Hedge Funds Are Selling PDL BioPharma Inc. (PDLI)
In this article we will take a look at whether hedge funds think PDL BioPharma Inc. (NASDAQ:PDLI) is a good investment right now. We check hedge fund...
Should You Buy PDL BioPharma Inc. (PDLI)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data....
PDL BioPharma Inc. (PDLI) Is Burning These Hedge Funds
Is PDL BioPharma Inc. (NASDAQ:PDLI) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research...
Were Hedge Funds Right About Flocking Into PDL BioPharma Inc. (PDLI) ?
Hedge funds are not perfect. They have their bad picks just like everyone else. Facebook, a stock hedge funds have loved dearly, lost nearly 40% of its...
Were Hedge Funds Right About Piling Into PDL BioPharma Inc. (PDLI)?
How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly traded companies. However...
Hedge Funds Are Buying PDL BioPharma Inc. (PDLI)
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in October...
Performance Of The Magic Formula Portfolio
Here’s a breakdown on how the Magic Formula Portfolio is performing. Since beginning this Shadow Stock Portfolio on June 1, 2016, it owns six stocks...
Is PDL BioPharma Inc (PDLI) Going to Burn These Hedge Funds?
There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating...
Performance Of The Enterprising Investor Portfolio
Here’s a breakdown on how the Enterprising Investor Portfolio is performing. Since beginning this Shadow Stock Portfolio on June 1, 2016, it owns...
Is PDL BioPharma Inc. (PDLI) Going to Burn These Hedge Funds?
We, at Insider Monkey, have gone over 700 13F filings that hedge funds and prominent investors are required to file by the government. The 13F filings...
Joel Greenblatt’s Top Picks Include United Therapeutics and Activision Blizzard
One of the funds we track is Joel Greenblatt‘s Gotham Asset Management, which recently filed its 13F form, disclosing its equity portfolio as at...
Vringo, Inc. (VRNG) News: Advertisement Patents, Royalty & Google Inc (GOOG)’s Claims
Editor’s Note: Vringo, Inc. (NASDAQ:VRNG), Google Inc (NASDAQ:GOOG), AOL, Inc. (NYSE:AOL), Marathon Patent Group Inc (OTCBB:MARA). Target Corporation...
Hedge Funds Are Betting On Celldex Therapeutics, Inc. (CLDX)
If you were to ask many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age. Although there are more than...
PDL BioPharma Inc. (PDLI): Hedge Fund and Insider Sentiment Unchanged, What Should You Do?
Should PDL BioPharma Inc. (NASDAQ:PDLI) investors track the following data? In the eyes of many market players, hedge funds are seen as overrated, old...
Here is What Hedge Funds and Insiders Think About Puma Biotechnology Inc (PBYI)
What’s a smart Puma Biotechnology Inc (NYSE:PBYI) investor to do? In today’s marketplace, there are dozens of methods market participants can...
Santarus, Inc. (SNTS): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
What should a smart Santarus, Inc. (NASDAQ:SNTS) investor do? In the financial world, there are a multitude of gauges investors can use to watch publicly...
What Hedge Funds Think About VIVUS, Inc. (VVUS)
Are you curious what the richest investors think about VIVUS, Inc. (NASDAQ:VVUS)? In the 21st century investor’s toolkit, there are dozens of metrics...
This MannKind Corporation (MNKD) Data Is Simply Jaw-Dropping. Wow.
MannKind Corporation (NASDAQ:MNKD) has gotten one of the biggest votes of confidence we’ve seen from the smart money, out of the entire stock market...
Alexion Pharmaceuticals, Inc. (ALXN): Extremely Expensive Drugs for Extremely Rare Diseases
The biotech industry is known for fast paced acquisitions and rapid market consolidation. Larger pharmaceutical companies headed towards patent cliffs...
AstraZeneca plc (ADR) (AZN), PDL BioPharma Inc. (PDLI): Tempting Healthcare Dividend Stocks to Avoid
When screening for health-care dividend stocks, it’s tempting to look for the ones with the highest yield. On the surface, larger dividend payments...
Lexicon Pharmaceuticals, Inc. (LXRX): Insiders Aren’t Crazy About It
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) investors should pay attention to an increase in activity from the world’s largest hedge funds recently...
MannKind Corporation (MNKD): Are Hedge Funds Right About This Stock?
MannKind Corporation (NASDAQ:MNKD) investors should pay attention to a decrease in hedge fund interest recently. According to most stock holders, hedge...
Here is What Hedge Funds Think About Puma Biotechnology Inc (PBYI)
Is Puma Biotechnology Inc (NYSE:PBYI) a buy here? Hedge funds are betting on the stock. The number of bullish hedge fund bets improved by 2 lately. In...
Do Hedge Funds and Insiders Love Celldex Therapeutics, Inc. (CLDX)?
Celldex Therapeutics, Inc. (NASDAQ:CLDX) investors should be aware of an increase in hedge fund interest lately. In the financial world, there are plenty...
PDL BioPharma Inc. (PDLI), Bridgepoint Education Inc (BPI): Magic Formula Stocks YTD and the Top 5
This article is removed because of technical problems
Do Hedge Funds and Insiders Love PDL BioPharma Inc. (PDLI)?
Is PDL BioPharma Inc. (NASDAQ:PDLI) a bargain? Investors who are in the know are taking a pessimistic view. The number of long hedge fund bets fell by...
Santarus, Inc. (SNTS): Insiders Are Buying, Should You?
Santarus, Inc. (NASDAQ:SNTS) investors should pay attention to a decrease in hedge fund interest in recent months. If you’d ask most shareholders...
MannKind Corporation (MNKD), PDL BioPharma Inc. (PDLI) & Optimer Pharmaceuticals, Inc. (OPTR): 2 Biotechs to Avoid, 1 to Buy
Keeping a close eye on two particular classes of investors can tell you a lot about how stocks might move in the future. Institutional investors have...
PDL BioPharma Inc. (PDLI), AbbVie Inc (ABBV): Two Scariest Dividend Stocks in Health Care
Combining nice dividends with a growing industry that comprises roughly one-fifth of the nation’s GDP should make for an attractive stock —...
Theravance Inc (THRX) Looks to Reward Shareholders by Splitting Into Two Distinct Companies
California-based Theravance Inc (NASDAQ:THRX)’s announcement that it would split into two distinct companies has drawn a sharply positive reaction...
Theravance Inc (THRX), Elan Corporation, plc (ADR) (ELN), GlaxoSmithKline plc (ADR) (GSK): Biotech Companies Breaking Up
If pharmaceutical companies can break up, why not biotech companies? Following in the footsteps of Abbott Laboratories (NYSE:ABT) spinning out its drug...
Is MannKind Corporation (MNKD) Going to Burn These Hedge Funds?
MannKind Corporation (NASDAQ:MNKD) was in 8 hedge funds’ portfolio at the end of December. MNKD shareholders have witnessed an increase in hedge...
PDL BioPharma Inc. (NASDAQ:PDLI): Insiders Are Dumping, Should You? – Santarus, Inc. (NASDAQ:SNTS), VIVUS, Inc. (NASDAQ:VVUS)
PDL BioPharma Inc. (NASDAQ:PDLI) has experienced a decrease in hedge fund interest recently. In the 21st century investor’s toolkit, there are a multitude...
Does PDL BioPharma Inc. (PDLI)’s Dividend Have Room to Soar?
With interest rates still sitting near record lows, investors looking for current income have been forced to move from fixed-income positions and into...
The 25 Highest-Yielding Dividend Stocks in March: Seadrill Ltd (SDRL), Boise Inc. (BZ), Windstream Corporation (WIN)
Dividend investing is popular again. Investors have taken to heart Jeremy Siegel’s studies, which show that higher-yielding stocks tend to offer...
The Fight Over This Biotech’s Cash: Elan Corporation, plc (ADR) (ELN)
Elan Corporation, plc (ADR) (NYSE:ELN) was nice enough to give us a little more detail on what it plans to do with the $3.25 million that the biotech...
